Rafael Holdings, Inc.

NYSE:RFL Stock Report

Market Cap: US$105.0m

Rafael Holdings Management

Management criteria checks 2/4

Rafael Holdings' CEO is Howard Jonas, appointed in Jun 2025, has a tenure of 1.17 years. total yearly compensation is $294.00K, comprised of 15% salary and 85% bonuses, including company stock and options. directly owns 35.69% of the company’s shares, worth $37.49M. The average tenure of the management team and the board of directors is 1.2 years and 2 years respectively.

Key information

Howard Jonas

Chief executive officer

US$294.0k

Total compensation

CEO salary percentage14.97%
CEO tenure1.2yrs
CEO ownership35.7%
Management average tenure1.2yrs
Board average tenure2yrs

Recent management updates

Recent updates

Seeking Alpha • Jun 29

Rafael Holdings: The Second Half Of Calendar 2026 Could Define This Company Forever

Summary Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the trial are expected in the second half of 2026. RFL has a runway of 4 to 5 quarters. RFL could end up borrowing money in the event of trial results getting delayed or FDA approval getting stretched. In my opinion, RFL does present a compelling investment case for risk-appetite investors. Conservative investors should wait until the trial results are out. Read the full article on Seeking Alpha
Analysis Article • Mar 26

Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Oct 11

Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Mar 21

Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)

Rafael Holdings, Inc.'s ( NYSE:RFL ) healthy profit numbers didn't contain any surprises for investors. We think this...
Analysis Article • Aug 04

We Think Rafael Holdings (NYSE:RFL) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Seeking Alpha • Dec 13

Rafael Holdings GAAP EPS of -$0.22

Rafael Holdings press release (NYSE:RFL): FQ1 GAAP EPS of -$0.22 (vs. -$5.88 Y/Y). As of Oct. 31, the company had cash, cash equivalents and marketable securities of $93.8M, which includes $33M in net proceeds from the sale of real estate assets on Aug. 22.
Seeking Alpha • Nov 16

Rafael stepping back from early-stage development in favor of acquisition, licensing

Rafael Holdings (NYSE:RFL) is putting the brakes on its early-stage development programs as part of an effort to reduce spending and instead focus on investing in, acquiring, or in-licensing clinical-stage candidates. CEO Bill Conkling said that by doing so, Rafael (RFL) has the "potential to achieve meaningful clinical milestones, which if successful, could improve the lives of patients and increase value for our shareholders." As of July 31, the Company had cash, cash equivalents and marketable securities of $63.2M, and then an additional $33M in net proceeds from the sale of real estate assets on August 23. The stock is down ~63% year to date.
Analysis Article • Jan 20

Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha • Nov 18

Rafael Holdings: A Coin Flip

RFL has a large bet on one drug for cancer treatment. This important bet just recently failed to succeed as a treatment for one type of cancer, with other studies ongoing. Aside from some real estate side income, RH is a generic biotech coin flip.
Seeking Alpha • Jun 21

Rafael Holdings announces merger with Rafael Pharmaceuticals

Zhanna Hapanovich/iStock via Getty Images Rafael Holdings (RFL) has added ~7.4% in the premarket after announcing a merger agreement with Rafael Pharmaceuticals, a private-owned late-stage oncology company in which the former and its subsidiaries has a majority stake. The president and CEO of Rafael Pharmaceuticals Sanjeev Luther will join the board of directors of the combined company which will be led by Ameet Mallik as the CEO and Howard Jonas as the chairman. The merged company will retain the name of Rafael
Analysis Article • Jan 25

What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition

A look at the shareholders of Rafael Holdings, Inc. ( NYSE:RFL ) can tell us which group is most powerful. Institutions...
Analysis Article • Dec 01

The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...

CEO Compensation Analysis

How has Howard Jonas's remuneration changed compared to Rafael Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 30 2026n/an/a

-US$33m

Jan 31 2026n/an/a

-US$33m

Oct 31 2025n/an/a

-US$31m

Jul 31 2025US$294kUS$44k

-US$31m

Apr 30 2025n/an/a

-US$23m

Jan 31 2025n/an/a

-US$50m

Oct 31 2024n/an/a

-US$40m

Jul 31 2024US$540kUS$40k

-US$34m

Apr 30 2024n/an/a

-US$29m

Jan 31 2024n/an/a

US$2m

Oct 31 2023n/an/a

-US$7m

Jul 31 2023US$40kUS$40k

-US$8m

Apr 30 2023n/an/a

-US$14m

Jan 31 2023n/an/a

-US$18m

Oct 31 2022n/an/a

-US$16m

Jul 31 2022US$1mUS$224k

-US$123m

Apr 30 2022n/an/a

-US$129m

Jan 31 2022n/an/a

-US$127m

Oct 31 2021n/an/a

-US$133m

Jul 31 2021US$333kUS$250k

-US$23m

Apr 30 2021n/an/a

-US$18m

Jan 31 2021n/an/a

-US$17m

Oct 31 2020n/an/a

-US$10m

Jul 31 2020US$250kUS$250k

-US$10m

Compensation vs Market: Howard's total compensation ($USD294.00K) is below average for companies of similar size in the US market ($USD657.63K).

Compensation vs Earnings: Howard's compensation has been consistent with company performance over the past year.

CEO

Howard Jonas (70 yo)

1.2yrs
Tenure
US$294,000
Compensation

Mr. Howard S. Jonas is a Founder and Executive Chairman of Rafael Holdings, Inc. and serves as Chief Executive Officer & President from June 1, 2025. Mr. Jonas serves as Vice Chairman of the Board at Oriel...

Leadership Team

NamePositionTenureCompensationOwnership
Howard Jonas
CEO, President1.2yrsUS$294.00k35.69%
$ 37.5m
David Polinsky
Chief Financial Officer3.6yrsUS$527.35k0.34%
$ 361.8k
Joshua Fine
Chief Operating Officer1yrno data0.018%
$ 18.9k
Joyce Mason
Corporate Secretaryno datano datano data
1.2yrs
Average Tenure
60.5yo
Average Age

Experienced Management: RFL's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Howard Jonas
CEO, President9yrsUS$294.00k35.69%
$ 37.5m
Michael Weiss
Independent Director8.4yrsUS$75.13k0.27%
$ 286.6k
N. Fine
Ex-Officio Vice Chairman1.1yrsno data0.64%
$ 677.4k
Markus Sieger
Lead Independent Director1.4yrsno data0.42%
$ 443.8k
Susan Bernstein
Director2.6yrsno data0.0062%
$ 6.5k
Mark Stein
Independent Director2yrsUS$31.30k0.098%
$ 102.7k
Alan Grayson
Independent Directorless than a yearno data0.013%
$ 13.3k
2.0yrs
Average Tenure
67yo
Average Age

Experienced Board: RFL's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/07 09:29
End of Day Share Price 2026/08/07 00:00
Earnings2026/04/30
Annual Earnings2025/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rafael Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.